CUV clinuvel pharmaceuticals limited

Ann: CLINUVEL included in S&P/ASX 200 Index, page-7

  1. 4,567 Posts.
    lightbulb Created with Sketch. 348
    bubble.

    EPP patient population 4000 in the USA. say $30K per treatment non recurring i.e. it goes away( idont know the figure),

    $30,000x 4000 patients. $120M non recurring. Say double and i get $250M. So market is over valuing this significantly, valuation $2bn

    the pipeline cant be worth $2bn can it?
    Last edited by Nige456: 18/06/19
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.25
Change
0.490(4.17%)
Mkt cap ! $614.0M
Open High Low Value Volume
$11.80 $12.32 $11.79 $1.611M 133.0K

Buyers (Bids)

No. Vol. Price($)
1 600 $12.12
 

Sellers (Offers)

Price($) Vol. No.
$12.25 390 1
View Market Depth
Last trade - 16.10pm 22/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.